A Phase II Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Cisplatin (Primary) ; Panitumumab (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 04 Sep 2017 Status changed from active, no longer recruiting to completed.
- 11 Oct 2016 Results published in the Annals of Oncology
- 23 May 2016 Results assessing anti-EGFR targeted monoclonal antibody from this and other trial (see profile 60289) published in the Clinical cancer research: an official journal of the American Association for Cancer Research